Standout Papers

Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with ... 2014 2026 2018 2022 413
  1. Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type (2014)
    Zoran Gatalica, Carrie Snyder et al. Cancer Epidemiology Biomarkers & Prevention

Immediate Impact

5 by Nobel laureates 13 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Daniel A. Holterman being referenced

Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
2014 Standout
Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy
2003

Author Peers

Author Last Decade Papers Cites
Daniel A. Holterman 234 88 408 169 12 626
Nathan Cuka 295 119 562 249 9 724
Sterre T. Paijens 304 52 420 140 12 670
Shamayel Mohammed 360 48 583 110 17 718
Annegé Vledder 291 46 383 121 8 584
Bernadette Reyna Asuncion 173 77 412 296 16 639
John M. Wallmark 202 206 580 271 11 725
A. Colmenarejo 417 79 472 91 13 693
Jia-Bin Lu 162 47 365 81 10 596
Marcella Marconi 138 49 397 180 15 517
Klaus Kluck 135 71 421 235 14 654

All Works

Loading papers...

Rankless by CCL
2026